Ticker
XGNCompany Name
EXAGEN INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 185.93M | $ 19.07M | $ 2.46M | $ 0 | -11.58% |
3/31/2025 | $ 112.52M | $ 292K | $ -919K | $ 0 | 0.56% |
12/31/2024 | $ 60.32M | $ 198K | $ -861K | $ 0 | 1.1% |
9/30/2024 | $ 49.21M | $ 198K | $ -865K | $ 0 | 1.36% |
6/30/2024 | $ 41.73M | $ 231K | $ -885K | $ 0 | 1.57% |
3/31/2024 | $ 28.49M | $ 231K | $ -10.9M | $ 0 | 37.45% |
12/31/2023 | $ 30.51M | $ 306K | $ -10.94M | $ 0 | 34.85% |
9/30/2023 | $ 24.89M | $ 367K | $ -10.94M | $ 0 | 42.47% |
6/30/2023 | $ 46.02M | $ 394K | $ -10.88M | $ 0 | 22.77% |
3/31/2023 | $ 49M | $ 394K | $ -791K | $ 0 | 0.81% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for EXAGEN INC is calculated as follows: (-1 * CF - Equity [ $ -1.58M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -231K ]) / Market Cap [ $ 203.07M ]
(=) Shareholder Yield [ 0.89% ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |